8. HitGen ¥250,000,000
Round: Series B
Description: HitGen is a platform company based on its leading DNA-encoded library (DELs) technology for innovative drug discovery research.
Industry: Health Care
Location: Chengdu, Sichuan
Date of funding: 05/28
Total equity funding: ¥250,000,000
Page 11 of 19
